Feasebility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions

Medical Physics

Volumn 31, Issue 6, 2004, Pages 1452-1461

  Das, S K ^a   Miften, M M ^a   Zhou, S ^a   Bell, M ^b   Munley, M T ^c   Whiddon, C S ^a   Craciunescu, O ^a   Baydush, A H ^a   Wong, T ^a   Rosenman, J G ^b   Dewhirst, M W ^a   Marks, L B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CELL PROLIFERATION; COMPLIANCE CONTROL; DOSIMETRY; FLUORINE; PARTICLE BEAMS; PHOTONS; POSITRON EMISSION TOMOGRAPHY; POSITRONS; RADIOTHERAPY; TUMORS;

ACTIVITY DISTRIBUTION; CRITICAL STRUCTURES; DOSE DISTRIBUTIONS; DOSE-VOLUME HISTOGRAMS; FLUORINE-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHIES; FLUORODEOXYGLUCOSE; INTENSITY MODULATIONS; RADIOTHERAPY PLANNING;

SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ALGORITHM; ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; ESOPHAGUS; HEART; IMAGING SYSTEM; INTENSITY MODULATED RADIATION THERAPY; LUNG; LUNG CANCER; LUNG TUMOR; POSITRON EMISSION TOMOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINAL CORD; TARGET ORGAN; TREATMENT PLANNING; BIOPHYSICS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; RADIOGRAPHY; SCINTISCANNING; STATISTICS;

ALGORITHMS; BIOPHYSICS; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3042634478     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1750991     Document Type: Article

References (55)

1. J. G. Rosenman, E. P. Miller, G. Tracton, and T. J. Cullip, "Image registration: An essential part of radiation therapy treatment planning," Int. J. Radiat. Oncol., Biol., Phys. 40, 197-205 (1998).
2. L. B. Marks, D. P. Spencer, G. W. Sherouse, G. Bentel, R. Clough, K. Vann, R. Jaszczak, R. E. Coleman, and L. R. Prosnitz, "The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose-volume histogram," Int. J. Radiat. Oncol., Biol., Phys. 33, 65-75 (1995).
3. M. T. Munley, L. B. Marks, C. Scarfone, G. S. Sibley, E. F. Patz, Jr., T. G. Turkington, R. J. Jaszczak, D. R. Gilland, M. S. Anscher, and R. E. Coleman, "Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects," Lung Cancer 23, 105-114 (1999).
4. Y. Seppenwoolde, M. Engelsman, K. De Jaeger, S. H. Muller, P. Baas, D. L. McShan, B. A. Fraass, M. L. Kessler, J. S. A. Belderbos, L. J. Boersma, and J. V. Lebesque, "Optimizing radiation treatment plans for lung cancer using lung perfusion information," Radiother. Oncol. 63, 165-177 (2002).
5. J. M. Albes, B. M. Dohmen, U. Schott, E. Schulen, M. Wehrmann, and G. Ziemer, "Value of positron emission tomography for lung cancer staging," Eur. J. Surg. Oncol. 28, 55-62 (2002).
6. S. U. Berlangieri, A. M. Scott, S. R. Knight, G. J. Fitt, O. F. Hennessy, H. J. Tochon-Danguy, C. Peter Clarke, and W. John McKay, "F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer," Eur. J. Cardiothorac Surg. 16, S25-S30 (1999).
7. R. Chin, T. W. McCain, A. A. Miller, D. P. Dunagan, J. Acostamadiedo, L. Douglas Case, B. A. Harkness, L. P. Adler, and E. F. Haponik, "Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study," Lung Cancer 37, 1-6 (2002).
8. I. H. Shon, M. J. O'Doherty, and M. N. Maisey, "Positron emission tomography in lung cancer," Semin. Nucl. Med. 32, 240-271 (2002).
9. K. F. Hubner, J. A. Thie, G. T. Smith, A. C. Chan, P. S. Fernandez, and J. M. McCoy, "Clinical utility of FDG-PET in detecting head and neck tumors: A comparison of diagnostic methods and modalities," Clin. Positron Imag. 3, 7-16 (2000).
10. M. P. Mac Manus, K. Wong, R. J. Hicks, J. P. Matthews, A. Wirth, and D. L. Ball, "Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center," Int. J. Radiat. Oncol., Biol., Phys. 52, 351-361 (2002).
11. E. M. Marom, J. J. Erasmus, and E. F. Patz, Jr., "Lung cancer and positron emission tomography with fluorodeoxyglucose," Lung Cancer 28, 187-202 (2000).
12. T. R. Miller and P. W. Grigsby, "Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy," Int. J. Radiat. Oncol., Biol., Phys. 53, 353-359 (2002).
13. N. Nair, A. Ali, A. A. Green, G. Lamonica, H. Alibazoglu, B. Alibazoglu, E. F. Hollinger, and K. Ahmed, "Response of osteosarcoma to chemotherapy: Evaluation with F-18 FDG-PET scans," Clin. Positron Imag. 3, 79-83 (2000).
14. U. Nestle, D. Hellwig, S. Schmidt, N. Licht, K. Walter, D. Ukena, C. Rube, M. Baumann, and C.-M. Kirsch, "2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer," Mol. Imag. Biol. 4, 257-263 (2002).
15. C. A. B. Saunders, J. E. Dussek, M. J. O'Doherty, and M. N. Maisey, "Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer," Ann. Thorac. Surg. 67, 790-797 (1999).
16. H. van Tinteren, O. S. Hoekstra, E. F. Smit, J. H. A. M. van den Bergh, A. J. M. Schreurs, R. A. L. M. Stallaert, P. C. M. van Velthoven, E. F. I. Comans, F. W. Diepenhorst, and P. Verboom, "Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial," Lancet 359, 1388-1393 (2002).
17. M. B. Wallace, P. J. Nietert, C. Earle, M. J. Krasna, R. H. Hawes, B. J. Hoffman, and C. E. Reed, "An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/ laparoscopy," Ann. Thorac. Surg. 74, 1026-1032 (2002).
18. J. M. Zubeldia, M. Abou-Zied, and H. A. Nabi, "Evaluation of patients with known mesothelioma with 18F-fluorodeoxyglucose and PET: Comparison with computed tomography," Clin. Positron Imag. 3, 165 (2000).
19. Y. E. Erdi, K. Rosenzweig, A. K. Erdi, H. A. Macapinlac, Y.-C. Hu, L. E. Braban, J. L. Humm, O. D. Squire, C.-S. Chui, S. M. Larson, and E. D. Yorke, "Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET)," Radiother. Oncol. 62, 51-60 (2002).
20. R. J. Wong, D. T. Lin, H. Schoder, S. G. Patel, M. Gonen, S. Wolden, D. G. Pfister, J. P. Shah, S. M. Larson, and D. H. Kraus, "Diagnostic and prognostic value of F-18 fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma," J. Clin. Oncol. 20, 4199-4208 (2002).
21. N. C. Choi, A. J. Fischman, A. Niemierko, J.-S. Ryu, T. Lynch, J. Wain, C. Wright, P. Fidias, and D. Mathisen, "Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer," Int. J. Radiat. Oncol., Biol., Phys. 54, 1024-1035 (2002).
22. K. Dhital, C. A. B. Saunders, P. T. Seed, M. J. O'Doherty, and J. Dussek, "[18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer," Eur. J. Cardiothorac Surg. 18, 425-428 (2000).
23. N. Oyama, H. Akino, Y. Suzuki, H. Kanamaru, Y. Miwa, H. Tsuka, N. Sadato, Y. Yonekura, and K. Okada, "Prognostic value of 2-deoxy-2-[F-18]fluoro-D- glucose positron emission tomography imaging for patients with prostate cancer," Mol. Imag. Biol. 4, 99-104 (2002).
24. S. Shiomi, S. Nishiguchi, H. Ishizu, Y. Iwata, N. Sasaki, A. Tamori, D. Habu, T. Takeda, S. Kubo, and H. Ochi, "Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma," Am. J. Gastroenterol. 96, 1877-1880 (2001).
25. A. Buck, H. Schirrmeister, T. Kuhn, C. X. Shen, T. Kalker, J. Kotzerke, A. Dankerl, G. Glatting, S. Reske, and T. Mattfeldt, "FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters," Eur. J. Nucl. Med. Mol. Imag. 29, 1317-1323 (2002).
26. J. M. Pugsley, R. A. Schmidt, and H. Vesselle, "The Ki-67 index and survival in non-small cell lung cancer: A review and relevance to positron emission tomography," Cancer 8, 222-233 (2002).
27. R. Bos, J. J. M. van der Hoeven, E. van der Wall, P. van der Groep, P. J. van Diest, E. F. I. Comans, U. Joshi, G. L. Semenza, O. S. Hoekstra, A. A. Lammertsma, and C. F. M. Molthoff, "Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography," J. Clin. Oncol. 20, 379-387 (2002).
28. R. Jacob, H. J. Welkoborsky, W. J. Mann, M. Jauch, and R. Amedee, "Fluorine-18 fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck," ORL 63, 307-313 (2001).
29. A. Dimitrakopoulou-Strauss, L. G. Strauss, M. Schwarzbach, C. Burger, T. Heichel, F. Willeke, G. Mechtersheimer, and T. Lehnert, "Dynamic PET F-18-FDG studies in patients with primary and recurrent soft-tissue sarcomas: Impact on diagnosis and correlation with grading," J. Nucl. Med. 42, 713-720 (2001).
30. N. Avril, M. Menzel, J. Dose, M. Schelling, W. Weber, F. Janicke, W. Nathrath, and M. Schwaiger, "Glucose metabolism of breast cancer assessed by F-18-FDG PET: Histologic and immunohistochemical tissue analysis," J. Nucl. Med. 42, 9-16 (2001).
31. S. Nerini-Molteni, E. Seregni, F. Crippa, L. Maffioli, C. Botti, and E. Bombardieri, "Uptake of tritiated thymidine, deoxyglucose and methionine in three lung cancer cell lines: Deoxyglucose uptake mirrors tritiated thymidine uptake," Tumour Biol. 22, 92-96 (2001).
32. H. Vesselle, R. A. Schmidt, J. M. Pugsley, M. Li, S. G. Kohlmyer, E. Vallieres, and D. E. Wood, "Lung cancer proliferation correlates with F-18 fluorodeoxyglucose uptake by positron emission tomography," Clin. Cancer Res. 6, 3837-3844 (2000).
33. T. A. D. Smith and J. Titley, "Deoxyglucose uptake by a head and neck squamous carcinoma: Influence of changes in proliferative fraction," Int. J. Radiat. Oncol., Biol., Phys. 47, 219-223 (2000).
34. K. Higashi, Y. Ueda, M. Yagishita, U. Arisaka, A. Sakurai, M. Oguchi, H. Seki, Y. Nambu, H. Tonami, and I. Yamamoto, "FDG PET measurement of the proliferative potential of non-small cell lung cancer," J. Nucl. Med. 41, 85-92 (2000).
35. A. C. Kole, B. E. C. Plaat, H. J. Hoekstra, W. Vaalburg, and W. M. Molenaar, "FDG and L-1-C-11-tyrosine imaging of soft-tissue tumors before and after therapy," J. Nucl. Med. 40, 381-386 (1999).
36. D. Osborne, R. Jaszczak, R. E. Coleman, K. Greer, and M. Lischko, "In vivo regional quantitation of intra-thoracic Tc-99m using spect-concise communication," J. Nucl. Med. 23, 446-450 (1982).
37. D. Osborne, R. J. Jaszczak, K. Greer, M. Lischko, and R. E. Coleman, "Spect quantification of technetium-99m microspheres within the canine lung," J. Comput. Assist. Tomogr. 9, 73-77 (1985).
38. S. Kristersson, S. E. Lindel, and L. Svanberg, "Prediction of pulmonary function loss due to peumonectomy using Xe-radiospirometry," Chest 62, 694-698 (1972).
39. J. A. Wernly, T. R. Demeester, P. T. Kirchner, P. D. Myerowitz, D. E. Oxford, and H. M. Golomb, "Clinical-value of quantitative ventilation-perfusion lung scans in the surgical-management of bronchogenic-carcinoma," J. Thorac. Cardiovasc. Surg. 80, 535-543 (1980).
40. W. F. Bria, D. J. Kanarek, and H. Kazemi, "Prediction of postoperative pulmonary-function following thoracic operations-Value of ventilation-perfusion scanning," J. Thorac. Cardiovasc. Surg. 86, 186-192 (1983).
41. L. Xing, C. Cotrutz, S. Hunjan, A. L. Boyer, E. Adalsteinsson, and D. Spielman, "Inverse planning for functional image-guided intensity-modulated radiation therapy," Phys. Med. Biol. 47, 3567-3578 (2002).
42. M. Alber, F. Paulsen, S. M. Eschmann, and H. J. Machulla, "On biologically conformal boost dose optimization," Phys. Med. Biol. 48, N31-N35 (2003).
43. E. J. Hall, Radiobiology for the Radiologist, 4th ed. (J. B. Lippincott Company, Philadelphia, 1994).
44. L. B. Marks, G. W. Sherouse, M. T. Munley, G. C. Bentel, and D. P. Spencer, "Incorporation of functional status into dose-volume analysis," Med. Phys. 26, 196-199 (1999).
45. A. Niemierko, "Reporting and analyzing dose distributions: a concept of equivalent uniform dose," Med. Phys. 24, 103-110 (1997).
46. M. V. Graham, J. A. Purdy, B. Emami, W. Harms, W. Bosch, M. A. Lockett, and C. A. Perez, "Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)," Int. J. Radiat. Oncol., Biol., Phys. 45, 323-329 (1999).
47. L. B. Marks, M. T. Munley, G. C. Bentel, S. M. Zhou, D. Hollis, C. Scarfone, G. S. Sibley, F. M. Kong, R. Jirtle, R. Jaszczak, R. E. Coleman, V. Tapson, and M. Anscher, "Physical and biological predictors of changes in whole-lung function following thoracic irradiation," Int. J. Radiat. Oncol., Biol., Phys. 39, 563-570 (1997).
48. M. L. Hernando, L. B. Marks, G. C. Bentel, S. M. Zhou, D. Hollis, S. K. Das, M. Fan, M. T. Munley, T. D. Shafman, M. S. Anscher, and P. A. Lind, "Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer," Int. J. Radiat. Oncol., Biol., Phys. 51, 650-659 (2001).
49. B. Emami, J. Lyman, A. Brown, L. Coia, M. Goitein, J. E. Munzenrider, B. Shank, L. J. Solin, and M. Wesson, "Tolerance of normal tissue to therapeutic irradiation," Int. J. Radiat. Oncol., Biol., Phys. 21, 109-122 (1991).
50. G. Gagliardi, I. Lax, and L. E. Rutqvist, "Partial irradiation of the heart," Semin Radiat. Oncol. 11, 224-233 (2001).
51. M. K. Martel, W. M. Sahijdak, R. K. Ten Haken, M. L. Kessler, and A. T. Turrisi, "Fraction size and dose parameters related to the incidence of pericardial effusions," Int. J. Radiat. Oncol., Biol., Phys. 40, 155-161 (1998).
52. S. K. Das, M. Bell, L. B. Marks, and J. R. Rosenman, "An evaluation of the utility of modulated electron beams in intensity modulated radiotherapy, using automatic selection of beam energies and orientations," Int. J. Radiat. Oncol., Biol., Phys. (in press).
53. S. Derycke, W. R. T. De Gersem, B. B. R. Van Duyse, and W. C. J. De Neve, "Conformal radiotherapy of stage III non-small cell lung cancer: A class solution involving non-coplanar intensity-modulated beams," Int. J. Radiat. Oncol., Biol., Phys. 41, 771-777 (1998).
54. S. X. Chang, T. J. Cullip, J. G. Rosenman, P. H. Halvorsen, and J. E. Tepper, "Dose optimization via index-dose gradient minimization," Med. Phys. 29, 1130-1146 (2002).
55. M. A. Socinski, L. B. Marks, J. Garst, G. S. Sibley, W. Blackstock, A. Turrisi, J. Herndon, S. Zhou, M. Anscher, J. Crawford, T. Shafman, and J. Rosenman, "Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: A preliminary report of a phase I dose escalation trial from the Carolina Conformal Therapy Consortium," Oncologist 6, 20-24 (2001).